PLP-Logo-with-White-Letters-compressed-1-e1730398035823
0
$0.00
0
$0.00
PE-22-28 10mg
PE-22-28 10mg - Image 2
PE-22-28 10mg - Image 3
PE-22-28 10mg - Image 4
PE-22-28 10mg - Image 5
PE-22-28 10mg - Image 6

PE-22-28 10mg

Customer Review 0
Rated 5 out of 5

$59.99

Researched Benefits:

  • Selective TREK-1 potassium channel antagonist for investigating antidepressant-like signaling pathways
  • Facilitates analysis of hippocampal brain-derived neurotrophic factor expression and activation
  • Supports research on glutamatergic neurotransmission modulation and synaptic plasticity in assays
  • Enables evaluation of rapid-acting neurogenic responses within controlled cellular assay models
Share it :
Payment-Icon.png
International Shipment

Your orders are shipped seamlessly between countries

30 Days Warranty

You have the right to return your orders within 30 days.

Secure Payment

Your payments are secure with our private security network.

Description

PE-22-28 10mg is a potent, short-chain research peptide (7 amino acids) derived from the spadin sequence and recognized for its high-affinity inhibition of the TREK-1 potassium channel. Manufactured from premium raw materials with state-of-the-art synthesis techniques, our PE-22-28 offers exceptional purity and stability, supporting rigorous neurological and psychiatric research applications.

Key Features:

  • ≥95 % purity verified through rigorous HPLC analysis

  • Consistent batch-to-batch quality under cGMP-aligned production standards

  • Supplied lyophilized to ensure long-term stability when stored at −20 °C

Applications:

  • Investigating rapid-onset antidepressant mechanisms and mood stabilization

  • Exploring hippocampal neurogenesis and synaptic plasticity pathways

  • Studying neuroprotection and recovery following ischemic stroke or traumatic brain injury

  • Evaluating TREK-1 channel modulation in neurodegenerative disease models

Specifications and Documentation

  • Material Safety Data Sheet (MSDS): Coming Soon.

  • Handling and Storage Instructions: Coming Soon.

PE-22-28 10 mg stands out in pre-clinical neuroscience for its capacity to induce rapid neurochemical and behavioral adaptations, making it an invaluable tool for researchers probing novel therapeutic avenues in mental health and neuroprotection.

0